Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Experimental & Molecular Medicine|July 24, 2004
Molecular technology and the recombinant TSH have changed diagnostics of thyroid carcinoma with positive I-131 whole body scan but low serum thyroglobulinLiliana Montella, Michele Caraglia, Alberto Abbruzzese, et al.
Oncology|September 6, 2018
Maintenance Therapy with Biweekly Cetuximab: Optimizing Schedule Can Preserve Activity and Improves Compliance in Advanced Head and Neck CancerRaffaele Addeo, Liliana Montella, Amerigo Mastella, et al.
Cancer|March 29, 2002
Somatostatin analogs and prednisone in advanced refractory thymic tumorsGiovannella Palmieri, Liliana Montella, Angelo Martignetti, et al.
Biomedicines|December 24, 2021
Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK SignalingLiliana Montella, Margaret Ottaviano, Vittorio Riccio, et al.
Cancers|April 13, 2023
Targeting HDAC2-Mediated Immune Regulation to Overcome Therapeutic Resistance in Mutant Colorectal CancerMariarosaria Conte, Annabella Di Mauro, Lucia Capasso, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Somatostatin receptor expression in thymic tumorsDiego Ferone, Liliana Montella, Annarosaria De Chiara, et al.
Clinical Colorectal Cancer|November 28, 2007
Atypical cutaneous lymphoid hyperplasia induced by chemotherapy in a patient with advanced colon carcinomaRaffaele Addeo, Liliana Montella, Alfonso Baldi, et al.
Tumori|November 10, 2005
Fatal immunodeficiency in a patient with thymoma and Good's syndromeLiliana Montella, Ghassam Merkabaoui, Laura Vitiello, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 16, 2009
Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reportsLiliana Montella, Raffaele Addeo, Vincenzo Faiola, et al.
Frontiers in Oncology|May 1, 2024
Case report: An ultrasound-based approach as an easy tool to evaluate hormone receptor-positive HER-2-negative breast cancer in advanced/metastatic settings: preliminary data of the Plus-ENDO studyLiliana Montella, Luigi Di Marino, Maria Adele Marino, et al.
Pageof 7